Taking back control: The experience of adults using semaglutide and tirzepatide for [PMID: 41399811] Laboratory literature summary: Taking back control: The experience of adults using semaglutide and tirzepatide for metabolic research models investigation A
Patients with active suicidal ideation, recent psychiatric hospitalization, or unstable bipolar disorder should not start a GLP-1 agent through any telehealth platform without documented coordination with their treating psychiatrist
50 / 300 /
Tirzepatide (Mounjaro/Zepbound) mimics two hormones (GLP-1 and GIP)
Beyond regular screening with mammography or MRI, some people with inherited genetic mutations that greatly increase breast cancer risk choose preventive surgery, including prophylactic mastectomy
[8] [9] Nevertheless, any medication that affects appetite, weight, and metabolic function may have secondary effects on mood and overall mental health, which is why monitoring remains important